The latest instructions from medical insurance: How much does platinib cost after it is included in medical insurance?

Although the original drug Pralsetinib (Pralsetinib) has been launched in China, it has not yet entered the ranks of medical insurance reimbursement through the relevant policies for inclusion in medical insurance dramas.如果普拉替尼进入医保，其价格会根据报销比例调整价格，不同地区报销比例不同，报销后的价格会存在些许差异，因此患者需要咨询当地医保局或医院等地了解。

Platinib is an effective targeted therapy for tumors caused by a specific gene mutation. It can be used to treat cancers in adults and children who carry RET gene rearrangements or mutations. RET gene mutations are one of the causes of many types of tumors, including thyroid cancer, lung cancer, colorectal cancer, etc. The indications for Platinib include patients with locally advanced or metastatic thyroid cancer who have RET gene rearrangements who have previously undergone thyroidectomy and patients with recurrent or metastatic non-small cell lung cancer (NSCLC) who have RET gene rearrangements. Platinib inhibits the growth and spread of tumors by inhibiting the mutated RET protein and blocking its signaling pathway.

The original drug Platinib currently on the market in China, a common price of 120 pills per box may be around RMB 60,000. The price of the European version of the original Platinib drug sold overseas may be around 40,000 yuan per box of 60 pills, and the price of the American version may be around 150,000 yuan per box (the price may fluctuate due to exchange rates), which is expensive. Generic drugs of Platinib are also available for sale overseas. The drug ingredients are basically the same as those of the original drugs at home and abroad. The price of each box of 120 pills may be more than 4,000 yuan (the price may fluctuate due to the exchange rate).